During the past decade, Hospital Universitário Maria Aparecida Pedrossian conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitário Maria Aparecida Pedrossian" #1 collaborator was "Grupo Fleury" with 1 trials as a collaborator, "Ministry of Health, Brazil" with 1 trials as a collaborator and "Sinovac Life Sciences Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitário Maria Aparecida Pedrossian" are "Acute Coronary Syndrome" (1 trials), "Acute MI" (1 trials), "COVID-19" (1 trials), "Cardiovascular Diseases" (1 trials) and "Genetic Predisposition to Disease" (1 trials). Many other conditions were trialed in "Hospital Universitário Maria Aparecida Pedrossian" in a lesser frequency.

Most popular intervention types in "Hospital Universitário Maria Aparecida Pedrossian" are "Biological" (1 trials), "Drug" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adsorbed COVID-19 (inactivated) Vaccine" (1 trials), "Antiplatelet Monotherapy" (1 trials), "Exposure to genetics (polygenic)" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitário Maria Aparecida Pedrossian" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitário Maria Aparecida Pedrossian". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Universitário Maria Aparecida Pedrossian, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitário Maria Aparecida Pedrossian, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".